MOLECULAR IMPACT OF PHARMACOLOGIC THERAPIES ON NF1 SKELETAL DISEASE

$128,959FY2022Defense Health AgencyDOD

The University Of Texas Southwestern Medical Center

Investigators

View source on USAspending →